L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro.
@article{Schmitt2015LdopaI, title={L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro.}, author={Ina Schmitt and Oliver Kaut and Hassan Khazneh and Laura deBoni and Ashar Ahmad and Daniela Berg and Christine Klein and Holger Fr{\"o}hlich and U W{\"u}llner}, journal={Movement disorders : official journal of the Movement Disorder Society}, year={2015}, volume={30 13}, pages={ 1794-801 } }
BACKGROUND
Increasing gene dosages of α-synuclein induce familial Parkinson's disease (PD); thus, the hypothesis has been put forward that regulation of gene expression, in particular altered α-synuclein gene methylation, might be associated with sporadic PD and could be used as a biological marker.
METHODS
We performed a thorough analysis of α-synuclein methylation in bisulfite-treated DNA from peripheral blood of 490 sporadic PD patients and 485 healthy controls and in addition analyzed the… CONTINUE READING
Topics from this paper.
Citations
Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS
Identification of potential blood biomarkers for Parkinson’s disease by gene expression and DNA methylation data integration analysis
VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED
Neuropsychiatric Aspects of Healthy Aging: an Epidemiological Approach : Neuropsychiatrische aspecten van gezond ouder worden: een epidemiologische benadering
VIEW 3 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED
The Effect of Dopamine on Gene Expression of Alpha-synuclein and Transcription Factors GATA-1, GATA-2, and ZSCAN21 in Parkinson’s Disease
VIEW 4 EXCERPTS
CITES RESULTS
HIGHLY INFLUENCED
Epigenetic Biomarkers for Parkinson’s Disease: From Diagnostics to Therapeutics
VIEW 8 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED
CpG and Non-CpG Methylation in Epigenetic Gene Regulation and Brain Function
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED
Genome-wide brain DNA methylation analysis suggests epigenetic reprogramming in Parkinson disease
VIEW 1 EXCERPT
CITES METHODS